This website is intended for healthcare professionals

Eribulin

Systemic anti-cancer therapy delivery in the home: a service model

Findings from the EMBRACE phase 3 clinical trial showed that eribulin significantly improves overall survival relative to treatment of physician's choice in patients with heavily pretreated metastatic...

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP